Cysoni is a bionic device that paces the heart with real-time respiratory modulation. The innovation stems from the idea that heart rate increases and decreases with each breath in normal physiology, termed ‘respiratory sinus arrhythmia’ (RSA)
Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread
Facility marks cornerstone of $50 billion investment in medicines R&D and manufacturing in America
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
Investment to expand manufacturing and global medicine supply capacity
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
Subscribe To Our Newsletter & Stay Updated
